5-(t-Butyldimethylsilyloxy)-2-methoxyphenylboronic acid, 98%, 250mg

5,6-Dichlorobenzo[d][1,3]dioxole, 95.0%, 1g

1-(2-ethoxyethyl)-1,4-diazepane, 95.0%, 5g

Azomethine H hydrate, min. 95%, pa, 5 g, plastic packaging.

1H-Benzo[d][1,2,3]triazole-5-carbonitrile, 95.0%, 5g

(R)-1-tert-Butyl 2-methyl 5-oxopyrrolidine-1,2-dicarboxylate, 95.0%, 1g

9-Methyl-9h-purine-6-carboxylic acid, 95%, 1g

Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-(4-iodophenyl)propanoate, 98%, 250mg

(S)-Oxiran-2-ylmethyl 4-nitrobenzenesulfonate, 98%, 100g

Ethyl 3-Furoate, 97.0%, 1g

2'-Chloropropiophenone, 95.0%, 100g

(4-(Benzo[d]thiazol-2-yl)phenyl)methanol, 98%, 250mg

2-(Piperidin-4-yl)pyridine dihydrochloride, 98+%, 5g